Quality of Life and Late Effects

Created by: Ihrig , generated 2010/02/25 , last changed: 2010/03/02

Due to increasing cure rates quality of life and late effects are becoming more and more research objectives of the scientific community - furthermore quality of life and late effects are potential new endpoints for clinical trials. Research in this field helps to optimise trial design and aftercare of the patients.

Table of Content:

Internal Workshops
ELIC has organized a first ELN workshop on a major cross-sectional scientific issue for the different disease related ...
EORTC QoL Symposium: Video sessions available
EORTC, QoL, Quality of life, EORTC PROBE Project

European Treatment and Outcome Study

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe

European Science Foundation

The ELN is funded through a Research Networking Programme (RNP), initiated by the European Science Foundation

ELN Foundation

The ELN Foundation is a non-profit charitable organisation, which supports the goals of the European LeukemiaNet

Video Clips